Latest Industry Insights

In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping research workflows.

Discover how explorations into the 3D structure of the genome and innovative multiomics platform technology are reshaping the future of precision medicine.

Dr. Joanne Mason discusses how Yourgene Health is advancing technologies that support long-read sequencing, reproductive health and accessible molecular diagnostics.

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.

Technology Networks spoke with Dr. Mark Van Oene, chief operating officer at PacBio, about an ambitious population genomics effort – the Korean Pangenome Reference Project.

Technology Networks asked a selection of start-up companies featured in the ELRIG Drug Discovery 2025 Breakthrough Zone how their technology could help realize the full capabilities of precision medicine.

At this year’s American Society of Human Genetics (ASHG) meeting, Ultima Genomics drew attention for its ambitious goal of making large-scale omics research more accessible and affordable.

In this Q&A, Pratt discusses a recent study comparing multiplex droplet digital PCR (ddPCR) with traditional quantitative PCR (qPCR), highlighting key methodological differences, assay validation strategies and the advantages of ddPCR.

At ASHG, Illumina launches 5-base and shows exciting results from constellation, a breakthrough technology offering long-range genomic insights from unfragmented DNA.

Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.